TheProfitWatch

LYEL - Lyell Immunopharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
17.77 0.64 (3.6%) --- --- 0.16 (0.88%) --- 0.64 (3.6%) --- ---

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.89
Diluted EPS:
-2.89
Basic P/E:
-6.3702
Diluted P/E:
-6.3702
RSI(14) 1m:
100.0
VWAP:
18.29
RVol:

Events

Period Kind Movement Occurred At

Related News